ICD-10 Code C81.2A | Mixed cellularity Hodgkin lymphoma, in remission Symptoms, Diagnosis, Billing

Mixed cellularity Hodgkin lymphoma, in remission is a subtype of Hodgkin lymphoma characterized by a predominance of mixed inflammatory cells. This condition is clinically significant as it indicates a response to treatment and the absence of active disease. The ICD-10 Code C81.2A facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively track treatment outcomes and resource utilization.

What is ICD-10 Code C81.2A for Mixed cellularity Hodgkin lymphoma, in remission?

ICD-10 Code C81.2A represents Mixed cellularity Hodgkin lymphoma, in remission, a condition where the patient has responded to treatment, resulting in the absence of detectable disease. This code should be used in clinical documentation and billing when a patient has been diagnosed with this specific subtype of Hodgkin lymphoma and is currently in a state of remission, reflecting the need for ongoing monitoring and follow-up care.

ICD-10 Code C81.2A – Clinical Definition and Explanation of Mixed cellularity Hodgkin lymphoma, in remission

Mixed cellularity Hodgkin lymphoma, in remission, is characterized by the presence of various immune cells, including Reed-Sternberg cells, within the lymphatic system. This subtype is associated with a favorable prognosis when treated effectively. Continuous monitoring is essential to ensure that the disease remains in remission and to manage any potential complications.

Key Clinical Features:

• Presence of Reed-Sternberg cells in lymphoid tissue.
• Commonly presents with lymphadenopathy and systemic symptoms.
• Typically affects young adults, with a slight male predominance.
• Requires regular follow-up to monitor for recurrence.

ICD-10 Code C81.2A for Mixed cellularity Hodgkin lymphoma, in remission – SOAP Notes & Clinical Use

ICD-10 Code C81.2A is utilized in SOAP notes to document the patient's remission status following treatment for Mixed cellularity Hodgkin lymphoma. This code plays a crucial role in capturing the patient's clinical history, ongoing assessments, and treatment plans, ensuring comprehensive care in both acute and chronic settings.

What Does ICD-10 Code C81.2A for Mixed cellularity Hodgkin lymphoma, in remission Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C81.2A connects subjective patient reports and objective clinical findings to a formal diagnosis of Mixed cellularity Hodgkin lymphoma, in remission. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code C81.2A – Mixed cellularity Hodgkin lymphoma, in remission

Management of Mixed cellularity Hodgkin lymphoma, in remission focuses on monitoring and supportive care to prevent recurrence. While antibiotic therapy is not typically indicated, disease-specific treatments may be necessary if complications arise.

Antibiotic Therapy:

Supportive Care:

• Regular follow-up appointments for monitoring.
• Symptom management, including pain control and nutritional support.
• Psychosocial support for emotional well-being.

Infection Control:

• Standard precautions to prevent infections.
• Education on recognizing signs of infection.

How to Document Symptoms of Mixed cellularity Hodgkin lymphoma, in remission (ICD-10 C81.2A) in SOAP Notes

Subjective:

• Patient reports feeling well with no new symptoms.
• Denies fever, night sweats, or weight loss.
• History of previous treatment for Hodgkin lymphoma.

Objective:

• Physical examination shows no lymphadenopathy.
• Vital signs within normal limits.
• Laboratory tests indicate stable blood counts.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Mixed cellularity Hodgkin lymphoma, in remission (ICD-10 Code C81.2A)

Assessment:

• Diagnosis: Mixed cellularity Hodgkin lymphoma, in remission.
• ICD-10 Code: C81.2A.
• No current symptoms or signs of recurrence.

Plan:

• Continue regular follow-up every 3-6 months.
• Educate patient on signs of recurrence.
• Monitor blood counts and imaging as needed.

Treatment & Plan Section for ICD-10 Code C81.2A – Mixed cellularity Hodgkin lymphoma, in remission

• Regular follow-up appointments to monitor for recurrence.
• Patient education on lifestyle modifications and symptom awareness.
• Routine laboratory tests to assess overall health.
• Psychosocial support services as needed.

Using ICD-10 Code C81.2A for Mixed cellularity Hodgkin lymphoma, in remission in Billing & SOAP Note Compliance

• Ensure accurate documentation of patient history and treatment response.
• Use C81.2A in settings where remission status is confirmed.
• Align treatment plans with clinical guidelines to support billing.
• Document any relevant symptoms or findings in SOAP notes.

Related ICD-10 Codes Often Used with Mixed cellularity Hodgkin lymphoma, in remission

ICD-10 Code C81.2A in Medical Billing and Insurance for Mixed cellularity Hodgkin lymphoma, in remission

ICD-10 Code C81.2A is essential for accurate billing and insurance claims related to Mixed cellularity Hodgkin lymphoma, in remission, particularly in hospital and outpatient settings.

Billing Notes:

• Document all relevant clinical findings and treatment responses.
• Use C81.2A in conjunction with other codes as necessary for comprehensive billing.
• Ensure that the diagnosis aligns with the services provided.

Common CPT Pairings: